Revolutionizing Hysteroscopic Tissue Removal Using the MyoSure® System
This supplement will review the technology, data and clinical experiences using the MyoSure® Hysteroscopic Tissue Removal System (Myosure Tissue Removal System).
Revolutionizing Hysteroscopic Tissue Removal Using the MyoSure® System
Abnormal uterine bleeding affects approximately 30% of women. Ultimately, direct visualization via hysteroscopy is known to provide a minimally invasive approach to visualize the endometrial cavity and enable subsequent removal of structural uterine lesions using electrosurgical loop or hysteroscopic morcellation. This supplement will review the technology, data and clinical experiences using the MyoSure® Hysteroscopic Tissue Removal System (Myosure Tissue Removal System).
Understanding VTE and bleeding risks in gynecologic noncancer surgery
April 15th 2024Delve into the nuanced risks of venous thromboembolism and major bleeding post-gynecologic noncancer surgery, exploring procedure-specific variations and the implications for thromboprophylaxis strategies.
Read More
Maternal history linked to uterine fibroid risk in Black women
April 11th 2024Delve into the findings of a recent study revealing the heightened risk of developing uterine fibroids among Black women with a maternal history of the condition, shedding light on crucial implications for patient care and advocacy.
Read More
